Mr. Richard Devience is a pharmacist who is specialized in Pharmacotherapy in Homewood, Illinois. Patients can reach him at 3153 183rd St, Homewood or contact him on 708-799-3666. Mr. Richard Devience is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Mr. Richard Devience speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mr. Richard Devience
Specialization:
Pharmacotherapy
Gender:
Male
Location:
3153 183rd St, Homewood, Illinois, 60430-2806
Phone:
708-799-3666
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. Richard Devience are as mentioned below.
NPI Number:
1952502205
NPI Enumeration Date:
31 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Richard Devience are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
12500 S. Pawnee, Palos Park, Illinois
Zip:
60464-1889
Phone Number:
708-799-3666
Fax Number:
--
Patients can reach Mr. Richard Devience at 3153 183rd St, Homewood, Illinois or can call on phone at 708-799-3666.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.